- Lobbying
- Lobbying by SK Americas, Inc.
Lobbying Relationship
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist | Covered positions? |
---|---|
Nicole Venable | Leg. Asst/Fellow, Rep. Lee Hamilton (1992-1993); Leg. Asst, Sen. Chuck Robb (1993-1996); Congressional Affairs Liaison, USTR (1996-1998); Sr Policy Adv, Rep. William J. Jefferson (1998-02); Chief of Staff, Rep. William J. Jefferson (2004-2005) |
Landon Stropko | Leg. Dir., Sen. Mike Enzi (2017-2018); Rep. Cynthia Lummis (2009-2016): Chief of Staff (DC), Leg. Dir., Sr. Leg. Asst, Leg. Asst; Rep. Barbara Cubin (2003-2008): Sr. Leg. Asst, Leg. Asst, Leg. Aide, Leg. Correspondent, Intern |
Annie D'Amato | Democratic Counsel, Senate Environment and Public Works Committee (2023); Professional Staff; Senate Environment and Public Works Committee (2019-2022) |
Kenny Roberts | Legislative Intern, Rep. Pierluisi (2011); Policy Aide, Sen. Rockefeller (2013) |
Joseph Smith | Special Assistant and Personal Aide to the Secretary, Department of the Interior, 2007-2009; Director of Operations, Department of the Treasury, 2017-2020 |
Christopher Gillott | Sen. Bill Cassidy: Deputy Chief of Staff, Policy (2018-2021); Legislative Dir (2013-2021); Sr Legislative Asst (2013); Rep. Bobby Jindal: Leg. Dir (2007-2008); Sr Legislative Asst (2005-2007); Sen. Kay Bailey Hutchison: Leg Aide (2003-2005) |
Samual Love | n/a |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Q1 Report
Registration
Issue(s) they said they’d lobby about: Electric vehicles, environmental issues, semiconductors, artificial intelligence (AI), biopharmaceuticals, and pharmaceutical ingredient manufacturing..
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate